Hologic, Inc. (NASDAQ:HOLX) Slid After Earnings - CMI, MHP, IDIX, HOLX

Lakeway, TX -- (SBWIRE) -- 02/06/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Cummins Inc. (NYSE:CMI) and Westport Innovations Inc. (USA)(NASDAQ:WPRT) JV says LA Metro, which has one of the largest natural gas transit fleets in North America, will order 550 New Flyer Xcelsior natural gas buses, powered with the Cummins Westport ISL G 8.9-liter engine to be deployed in 2014 and 2015, with an option to purchase an additional 350 buses in 2016.

How Should Investors Trade CMI After The Recent Movement? Find Out Here

The McGraw-Hill Companies, Inc. (NYSE:MHP) slides a new as the DOJ files its suit alleging S&P knowingly gave unwarranted AAA ratings to MBS in order to get more business from issuers. Just maybe there's a problem with the industry-issuer model? What was that Pacino movie ... "The whole system is out of order!" Shares of MHP slumped 10.70%.

Is MHP A Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) regains some of yesterday's post-session dip, but still trails the overall market after saying that it's discontinuing its clinical development program for two of its investigational hepatitis C drugs, after the FDA said the treatments would remain on clinical hold. The hold is related to the regulator's heart-safety concerns about rival Bristol-Myers Squibb's (BMY) BMS-986094, a treatment for the liver disease which belongs to the same class of drugs known as nucleotide polymerase inhibitors.

Is IDIX a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Hologic, Inc. (NASDAQ:HOLX) slips on a mixed FQ1 result late yesterday, beating on a per share basis but coming up just shy on the revenue side. Net profit plunged as the health- products company posted higher acquisition-related charges which masked strong revenue growth. Revenue from its breast-health segment grew by 2.5%, mostly on the growing installed base of the company's digital mammography systems, while its diagnostics revenue soared to $305.9M from $154.1M the year prior, getting a big boost from its Gen-Probe acquisition.

How Should Investors Trade HOLX After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.